Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer
about
Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologistWhat are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer?Therapeutic role of endoscopic ultrasound in pancreaticobiliary disease: A comprehensive reviewAdvances of stereotactic body radiotherapy in pancreatic cancerA current perspective on stereotactic body radiation therapy for pancreatic cancerTherapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study.Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapyCyberknife: A double edged sword?Normal tissue toxicity after small field hypofractionated stereotactic body radiation.Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump.Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patientsQuantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial.Role of endoscopic ultrasound in treatment of pancreatic cancerPredictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.Stereotactic body radiation therapy for nonresectable tumors of the pancreasAggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis.Feasibility of automated pancreas segmentation based on dynamic MRI.Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaFeasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.Chemoradiation in pancreatic adenocarcinoma: a literature review.The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.Adaptive motion mapping in pancreatic SBRT patients using Fourier transforms.Robotic radiosurgery in pancreatic cancer: A systematic review.The role of radiotherapy in management of pancreatic cancerA review of update clinical results of carbon ion radiotherapyA phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.Pancreatic cancer and SBRT: A new potential option?Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreasTreatment of locally advanced unresectable pancreatic cancer: a 10-year experience.Accuracy of marketing claims by providers of stereotactic radiation therapy.Image-guided radiosurgical ablation of intra- and extra-cranial lesions.Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer.Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapyComputer aided robotic radiosurgery.Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trialCyberKnife robotic radiosurgery system for tumor treatment.
P2860
Q26747145-4551F575-0940-45DF-B3AB-B51EFC01712EQ26748562-55D94A23-B817-4ABD-8F0C-ADF353441545Q26775348-FA4D5290-D768-437A-B812-1DB8295E99C6Q26781550-923E0316-1C31-478E-8327-FB0CCEB19DF4Q28077111-CC36EF1F-DE21-4A5D-AE0C-8EC2BDF0771DQ30381174-1281E6D2-6BF8-4284-8C67-EFCC307106F6Q30423279-22634C96-747A-44F6-ABE1-D10923FC22E7Q30443893-6F236182-F4F5-47B3-86BA-A67B82FE61DAQ30445404-731A5EDA-20E9-4D3C-BF87-D1AA324BE18FQ30484881-A0CFC757-EFF0-44CB-9D0B-B44AADCC3244Q33433915-50A7BC1E-43DB-4147-BF98-F98F435E1BF4Q33587876-707FFD6E-DAE8-4FE0-9703-87DF2F514FAAQ33612704-5FD1439D-781F-435E-AD90-8A3D5E240C1EQ33772958-DF3E3BE8-7DBB-422A-8116-33469A831DC5Q34072096-2FE764D3-2022-42F7-BF8D-42B295546E28Q34337930-4B7CDC41-0170-477F-AD69-11DF4A6840F8Q34342960-FE225F9F-3EC9-456A-BA67-32CF638B85CEQ34568226-83EA2337-3629-4DE8-AB49-54672F804809Q35202400-1D45F384-7FC5-4C68-B2FA-417D96E6A874Q35232033-536BDF23-40BE-4BAA-AA24-CB16CAE66CABQ35583949-BD6CE64B-7508-4ABA-9C8D-A42C940D86EBQ35695811-60E2D6CA-E3EC-4782-93BA-7296724002C5Q35744190-718EF882-1488-492B-807F-4042A8B32606Q35970200-E63CCFFA-36AF-445B-B568-D3B24A29E7D6Q36097189-BE7E9B78-A143-489A-BB6D-690638C93BB8Q36119520-23D3CAE1-4075-4AF9-A4D2-AB1349C47AC8Q36130588-4E1686FD-2747-4E29-8D13-F04C12C8EADFQ36133787-0E57A6D8-F0A9-45AD-BFA3-D95182359A43Q36231964-359671BE-3CCB-4C1B-8819-5D8B4DC2A41CQ36381222-3E0261B1-022C-4123-8BB4-5EF44AD7565EQ36534796-5D7E382E-303B-4A72-8FDB-88D580144FD7Q36546235-EE6DD6BF-D19C-45D8-93C8-CB8BE94A0362Q36558415-4995B4E6-CF4C-4AE6-BB17-17A2902B6AC3Q36563900-4BF0C0BB-44B5-43BF-A2AB-13C2DA13E5B0Q36626511-DCBE3BD8-0B65-45DF-8E0A-B0C9B1645FDDQ36632603-399175BC-BD0A-4A0B-976C-CC5ED8ECF956Q36666622-3E5F8EF1-E765-4F97-9593-8BFD6955781DQ36715792-8ABABF5B-4455-45B0-8D9A-611DE6A38B14Q36980782-F3F4CAB8-D676-4806-97D7-8359C70EE228Q37004652-0403F34A-9F31-4A0A-96D5-27AFCF870835
P2860
Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase II study to assess the e ...... lly advanced pancreatic cancer
@ast
Phase II study to assess the e ...... lly advanced pancreatic cancer
@en
Phase II study to assess the e ...... lly advanced pancreatic cancer
@nl
type
label
Phase II study to assess the e ...... lly advanced pancreatic cancer
@ast
Phase II study to assess the e ...... lly advanced pancreatic cancer
@en
Phase II study to assess the e ...... lly advanced pancreatic cancer
@nl
prefLabel
Phase II study to assess the e ...... lly advanced pancreatic cancer
@ast
Phase II study to assess the e ...... lly advanced pancreatic cancer
@en
Phase II study to assess the e ...... lly advanced pancreatic cancer
@nl
P2093
P3181
P1476
Phase II study to assess the e ...... lly advanced pancreatic cancer
@en
P2093
Anthony Ho
Erin Christofferson
George A Fisher
George P Yang
Jeffrey Norton
Karyn A Goodman
Quynh-Thu Le
Ralph Greco
Timothy Kuo
P3181
P356
10.1016/J.IJROBP.2005.07.002
P407
P577
2005-10-01T00:00:00Z